跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sanzepir-50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sanzepir-50
Approved
STANDARD
Sanzepir-50
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a013cf2025a0580c
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
a013cf2025a0580c
Drug Approval Philippines Name
Sanzepir-50
Product Name
Sanzepir-50
Registration Number
DRP-13480
Brand Name
Sanzepir-50
Generic Name
Epirubicin (as hydrochloride)
Dosage Form
Lyophilized Powder for Injection (IV)
Dosage Strength
50mg
Manufacturer
Admac Lifesciences
Trader
Unicare Healthsciences Pvt. Ltd.
Importer
AGB Pharmaceutical Trading & Consultancy Corporation
Distributor
AGB Pharmaceutical Trading & Consultancy Corporation
Issuance Date
27 February 2023
Expiry Date
27 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a013cf2025a0580c
Type
Standard
Back to Philippines FDA Approvals